Mentholatum

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Mentholatum
Generic name: METHYL SALICYLATE, DL-MENTHOL
Manufacturer: Lydia Co., Ltd.
Product type: HUMAN OTC DRUG
SPL set ID: e9db590f-b19a-3fe8-e053-2995a90a4e74
SPL ID: ffcab802-a76f-e425-e053-6294a90acf76
Version: 3
Effective date: 2023-07-06
Source export date: 2026-09-28
Source partition: 12
Source file: https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/663999d0fe1757c1e2cd13a4799d76d875f663e0bc57701092264ebe7febfc18/drug-label-0012-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:28:09

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Mentholatum	openfda.brand_name
generic name		METHYL SALICYLATE, DL-MENTHOL	openfda.generic_name
manufacturer name		Lydia Co., Ltd.	openfda.manufacturer_name
ndc	package	72988-0031-1	openfda.package_ndc
ndc	product	72988-0031	openfda.product_ndc
ndc11	package	72988003101	derived:openfda.package_ndc
rxcui		282812	openfda.rxcui
spl id		ffcab802-a76f-e425-e053-6294a90acf76	id
spl set id		e9db590f-b19a-3fe8-e053-2995a90a4e74	set_id
unii		L7T10EIP3A	openfda.unii
unii		LAV5U5022Y	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Flammable ■ Keep away from fire, flame, sparks and heated surfaces. Tight cap firmly. Stop use and ask a doctor if ■ Condition worsens or symptoms persist for more than 7days or clear up and occur again within a few days When using this product ■ Use only as direct ■ Avoid contact with eyes ■ Do not apply to wounds or damaged skin ■ Do not bandage tightly If pregnant or breast-feeding, ask a health professional before use Keep out of reach of childre

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.